<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d252">
    <sentence id="DDI-DrugBank.d252.s0" text="Although BETAGAN used alone has little or no effect on pupil size, mydriasis resulting from concomitant therapy with BETAGAN and epinephrine may occur.">
        <entity charOffset="9-15" id="DDI-DrugBank.d252.s0.e0" text="BETAGAN" type="brand"/>
        <entity charOffset="117-123" id="DDI-DrugBank.d252.s0.e1" text="BETAGAN" type="brand"/>
        <entity charOffset="129-139" id="DDI-DrugBank.d252.s0.e2" text="epinephrine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d252.s0.e0" e2="DDI-DrugBank.d252.s0.e1" id="DDI-DrugBank.d252.s0.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d252.s0.e0" e2="DDI-DrugBank.d252.s0.e2" id="DDI-DrugBank.d252.s0.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d252.s0.e1" e2="DDI-DrugBank.d252.s0.e2" id="DDI-DrugBank.d252.s0.p2" type="effect"/>
    <negationtags>Although BETAGAN used alone has little or &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; effect on pupil size, mydriasis resulting from concomitant therapy with BETAGAN and epinephrine may occur. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d252.s1" text="Close observation of the patient is recommended when a beta-blocker is administered to patients receiving catecholamine-depleting drugs such as reserpine, because of possible additive effects and the production of hypotension and/or marked bradycardia, which may produce vertigo, syncope or postural hypotension.">
        <entity charOffset="55-66" id="DDI-DrugBank.d252.s1.e0" text="beta-blocker" type="group"/>
        <entity charOffset="144-152" id="DDI-DrugBank.d252.s1.e1" text="reserpine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d252.s1.e0" e2="DDI-DrugBank.d252.s1.e1" id="DDI-DrugBank.d252.s1.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d252.s2" text="Patients receiving beta-adrenergic blocking agents along with either oral or intravenous calcium antagonists should be monitored for possible atrioventricular conduction disturbances, left ventricular failure and hypotension.">
        <entity charOffset="19-49" id="DDI-DrugBank.d252.s2.e0" text="beta-adrenergic blocking agents" type="group"/>
        <entity charOffset="89-107" id="DDI-DrugBank.d252.s2.e1" text="calcium antagonists" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d252.s2.e0" e2="DDI-DrugBank.d252.s2.e1" id="DDI-DrugBank.d252.s2.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d252.s3" text="In patients with impaired cardiac function, simultaneous use should be avoided altogether."/>
    <sentence id="DDI-DrugBank.d252.s4" text="The concomitant use of beta-adrenergic blocking agents with digitalis and calcium antagonists may have additive effects on prolonging atrioventricular conduction time.">
        <entity charOffset="23-53" id="DDI-DrugBank.d252.s4.e0" text="beta-adrenergic blocking agents" type="group"/>
        <entity charOffset="60-68" id="DDI-DrugBank.d252.s4.e1" text="digitalis" type="group"/>
        <entity charOffset="74-91" id="DDI-DrugBank.d252.s4.e2" text="calcium antagonist" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d252.s4.e0" e2="DDI-DrugBank.d252.s4.e1" id="DDI-DrugBank.d252.s4.p0" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d252.s4.e0" e2="DDI-DrugBank.d252.s4.e2" id="DDI-DrugBank.d252.s4.p1" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d252.s4.e1" e2="DDI-DrugBank.d252.s4.e2" id="DDI-DrugBank.d252.s4.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d252.s5" text="Phenothiazine-related compounds and beta-adrenergic blocking agents may have additive hypotensite effects due to the inhibition of each other s metabolism.">
        <entity charOffset="0-30" id="DDI-DrugBank.d252.s5.e0" text="Phenothiazine-related compounds" type="group"/>
        <entity charOffset="36-66" id="DDI-DrugBank.d252.s5.e1" text="beta-adrenergic blocking agents" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d252.s5.e0" e2="DDI-DrugBank.d252.s5.e1" id="DDI-DrugBank.d252.s5.p0" type="mechanism"/>
    </sentence>
</document>